Načítá se...
Erythropoietin serum levels, versus anaemia as risk factors for severe retinopathy of prematurity
BACKGROUND: Preterm infants with anaemia are treated with recombinant human erythropoietin (rhEPO). It is debated whether rhEPO treatment is a risk factor for retinopathy of prematurity (ROP). We evaluated longitudinal EPO and haemoglobin levels, blood transfusions and neonatal morbidities as risk f...
Uloženo v:
| Vydáno v: | Pediatr Res |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6422731/ https://ncbi.nlm.nih.gov/pubmed/30297879 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41390-018-0186-6 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|